The drug-resistant mpox cases follow an initial, unrelated cluster reported in California in late 2022-early 2023, and are the first involving multiple states, according to the report.

Cases of a dangerous, drug-resistant fungus have been confirmed in at least 17 states so far this year, with the Midwest seeing some of the highest numbers, including several in Illinois.